Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Merck & Co. discloses pneumococcal vaccines

June 2, 1997

Protein Sciences' influenza vaccine covered under U.S. patent

June 2, 1997

Pasteur Merieux Connaught launches combination vaccine with acellular component

May 29, 1997

Losartan effective in chronic renal allograft rejection

May 28, 1997

MC-1288 + ciclosporin for allograft rejection

May 26, 1997

Highlights of the 7th INWIN

May 26, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

VX-497: selective IMPDH inhibitor with potent immunosuppressive properties

May 22, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...